A copy of the poster is available at the following link: ESMO Poster May 2025 More information about the data CytoDyn presented at ESMO suggesting the novel mechanism of action of leronlimab for ...

"Assessing Safety and Clinical Outcomes of Rinvecalinase Alfa (DM199) in Acute Ischemic Stroke Patients Pre-treated with Intravenous Thrombolytics Only" The poster is P-704. On Thursday May 22 ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Universal and director Jon M. Chu's Wicked sequel, which was recently re-titled Wicked: For Good, is set to take flight this November, and the first poster has now been officially released online ...

All appears to be on track. Avacta WILL need more funds. That is obvious since they don't have any significant income or possibly no income (it's been a long time since the last milestone payment ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today a poster presentation of ...

UK-based biotech Avacta is one of such company, and aims to develop cheaper biologics which avoid many of these problems. The company's chief executive Alastair Smith set out the company's ...